Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Angst

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Fortschritte Der Kieferorthopadie|February 1, 1988
[The origin of man]R Angst
Folia Primatologica; International Journal of Primatology|January 1, 1971
[Variability of Urogale everetti]R Angst, P Mann
Folia Primatologica; International Journal of Primatology|January 1, 1971
[On the variability of Urogale everetti]R Angst, P Mann
Medical and Pediatric Oncology|December 24, 1997
"Pancreatoblastoma in childhood: the role of alpha-fetoprotein"E Bergstraesser, H Ohnacker, B Stamm, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1995
Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology GroupP Imbach, A Fuchs, W Berchtold, et al.
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|January 20, 2018
Impact of Single Center Treatment on Ewing Sarcoma 10-Year Long Term Survival RatesA H Krieg, S Gehmert, R Angst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label studyR von Moos, C B Caspar, B Thürlimann, et al.
Medical and Pediatric Oncology|January 1, 1994
Treatment of relapsing acute lymphoblastic leukemia in childhood. III. Experiences with 54 first bone marrow, nine isolated testicular, and eight isolated central nervous system relapses observed 1985-1989N von der Weid, B Wagner, R Angst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxelC Sessa, D Tosi, L Viganò, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Fortschritte Der Kieferorthopadie|February 1, 1988
[The origin of man]R Angst
Folia Primatologica; International Journal of Primatology|January 1, 1971
[Variability of Urogale everetti]R Angst, P Mann
Folia Primatologica; International Journal of Primatology|January 1, 1971
[On the variability of Urogale everetti]R Angst, P Mann
Medical and Pediatric Oncology|December 24, 1997
"Pancreatoblastoma in childhood: the role of alpha-fetoprotein"E Bergstraesser, H Ohnacker, B Stamm, et al.
Journal of Pediatric Hematology/Oncology|November 1, 1995
Boys but not girls with T-lineage acute lymphocytic leukemia (ALL) are different from children with B-progenitor ALL. Population-based data results of initial prognostic factors and long-term event-free survival. Swiss Pediatric Oncology GroupP Imbach, A Fuchs, W Berchtold, et al.
Acta Chirurgiae Orthopaedicae Et Traumatologiae Cechoslovaca|January 20, 2018
Impact of Single Center Treatment on Ewing Sarcoma 10-Year Long Term Survival RatesA H Krieg, S Gehmert, R Angst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 13, 2008
Renal safety profiles of ibandronate 6 mg infused over 15 and 60 min: a randomized, open-label studyR von Moos, C B Caspar, B Thürlimann, et al.
Medical and Pediatric Oncology|January 1, 1994
Treatment of relapsing acute lymphoblastic leukemia in childhood. III. Experiences with 54 first bone marrow, nine isolated testicular, and eight isolated central nervous system relapses observed 1985-1989N von der Weid, B Wagner, R Angst, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 11, 2009
Phase Ib study of weekly mammalian target of rapamycin inhibitor ridaforolimus (AP23573; MK-8669) with weekly paclitaxelC Sessa, D Tosi, L Viganò, et al.
Pageof 1